PropertyGrid Revolutionizes Real Estate Investment with Blockchain-Backed Assets, Opening Doors for Investors and Everyday Individuals

TAMPA, Fla., June 17, 2025 /PRNewswire/ — PropertyGrid, an innovative real estate technology platform, today announced its imminent public launch, poised to fundamentally enhance the liquidity and flexibility of real estate by transforming physical properties into blockchain-backed assets. This groundbreaking process led by industry leading professionals will facilitate safer, easier and more fluid transactions, making… Continue reading PropertyGrid Revolutionizes Real Estate Investment with Blockchain-Backed Assets, Opening Doors for Investors and Everyday Individuals

Wheels Up Announces Executive Leadership Changes to Align Go-To-Market Strategy and Accelerate Growth

ATLANTA, June 17, 2025 /PRNewswire/ — Wheels Up Experience Inc. (NYSE: UP), a leading provider of on-demand private aviation, today announced key executive leadership appointments that align the company’s go-to-market growth strategy with the evolving needs of its customers. “These leadership changes are a natural next step in our transformation journey,” said George Mattson, Chief Executive… Continue reading Wheels Up Announces Executive Leadership Changes to Align Go-To-Market Strategy and Accelerate Growth

Children’s Hospital of Philadelphia Researchers Spotlight Adults with Hypoplastic Left Heart Syndrome (HLHS) Thriving Without Transplants

Study Highlights Largest Single-Center Cohort of Adults with HLHS with Longest Follow-up PHILADELPHIA, June 17, 2025 /PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who underwent complex reconstructive surgery for hypoplastic left heart syndrome as newborns. In this cohort, more than 30% survived… Continue reading Children’s Hospital of Philadelphia Researchers Spotlight Adults with Hypoplastic Left Heart Syndrome (HLHS) Thriving Without Transplants

GetWhys Unveils Unified Data Capabilities: Expanding Proprietary Research Database to Include Internet and Organizational Data

Distinct, complementary data sources power GetWhys’ mission to deliver actionable, real-world insights for B2B GTM teams BOISE, Idaho, June 17, 2025 /PRNewswire/ — GetWhys, the B2B customer insights platform built to make research an effortless part of your workflow, today announced a major expansion of its data strategy. GetWhys now enables users to analyze and… Continue reading GetWhys Unveils Unified Data Capabilities: Expanding Proprietary Research Database to Include Internet and Organizational Data

PINE CLAIMS LAUNCHES TECH-ENABLED INDEPENDENT ADJUSTING FIRM DESIGNED FOR MODERN CARRIER NEEDS

Blending automation and experienced adjusters, Pine focuses on speed, transparency, and operational scale.  OLDSMAR, Fla., June 17, 2025 /PRNewswire/ — Pine Claims Solutions, Inc. (“Pine”) today announced the launch of its independent adjusting firm focused on property field claims. Built by former carrier-side leadership, Pine merges automation-driven workflows with licensed adjusters to increase speed-to-resolution and… Continue reading PINE CLAIMS LAUNCHES TECH-ENABLED INDEPENDENT ADJUSTING FIRM DESIGNED FOR MODERN CARRIER NEEDS

Startek® recognized with 5 Comparably Awards for excellence across leadership, career growth and team performance

–  Awards highlight Startek’s focus on people-first culture and business-aligned talent development DENVER, June 17, 2025 /PRNewswire/ — Startek®, a digital-first global customer experience (CX) solutions provider, announced today that it has been recognized with five Comparably Awards for 2025. The company was honored in the categories of Best Career Growth, Best Leadership Teams, Best… Continue reading Startek® recognized with 5 Comparably Awards for excellence across leadership, career growth and team performance

TrueRoll and DEVNET Partner to Streamline Homestead Exemption Processing

Strategic collaboration helps assessor offices reduce manual workloads and simplify exemption workflows through integrated automation. CHICAGO, June 17, 2025 /PRNewswire/ — TrueRoll and DEVNET have announced a new partnership to help Illinois counties simplify and automate key parts of homestead exemption administration. The collaboration is designed to reduce manual workloads for assessor offices and create a… Continue reading TrueRoll and DEVNET Partner to Streamline Homestead Exemption Processing

Bob Evans® Turns Up the Heat for National Mac and Cheese Day with a Cheesy Giveaway

14 lucky fans will win a one-year supply of America’s favorite* refrigerated macaroni & cheese and exclusive summer-themed prizes NEW ALBANY, Ohio, June 17, 2025 /PRNewswire/ — In celebration of National Mac and Cheese Day on July 14, Bob Evans®, the brand known for its comforting refrigerated dinner sides, is heating up summer with a craveable… Continue reading Bob Evans® Turns Up the Heat for National Mac and Cheese Day with a Cheesy Giveaway

Anywhere Announces Proposed Offering of Senior Secured Second Lien Notes

MADISON, N.J., June 17, 2025 /PRNewswire/ — Anywhere Real Estate Inc. (“Anywhere” or the “Company”) (NYSE: HOUS) announced today that Anywhere Real Estate Group LLC (the “Issuer”) and Anywhere Co-Issuer Corp. (the “Co-Issuer” and together with the Issuer, the “Issuers”), each a subsidiary of the Company, are proposing to issue, subject to market and other conditions,… Continue reading Anywhere Announces Proposed Offering of Senior Secured Second Lien Notes

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CRANFORD, N.J., June 17, 2025 /PRNewswire/ — Citius Oncology, Inc. (“Citius Oncology”) (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), today announced that preparations for the commercial launch of LYMPHIR™, an FDA-approved immunotherapy for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL), are nearing completion. The Company… Continue reading Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025